(1 - 25 von 67
)
MorphoSys AG Announcements | MorphoSys AG Investegatewww.investegate.co.uk › gnw › morphosys-announ...
www.investegate.co.uk
· ... Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG. "In total, our collaboration with Novartis has resulted in eight clinical antibodies to ...
MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial ...www.technologynetworks.com › news › morphosys...
www.technologynetworks.com
· ... industry" commented Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG. "During the course of this year, the MorphoSys pipeline has ...
MorphoSys Signs Manufacturing Agreement with Boehringer ...www.manufacturing.net › home › news › morphosy...
www.manufacturing.net
Marlies Sproll, Chief Scientific Officer of MorphoSys AG. "Additionally, establishing a commercial manufacturing process with Boehringer Ingelheim early in the ...
MorphoSys Strengthens Patent Position on MOR202 Program ...www.technologynetworks.com › m...
www.technologynetworks.com
... multiple sclerosis and MOR208 in chronic lymphocytic leukemia," commented Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG.
sortiert nach Relevanz / Datum